James W. Scheffel

501 total citations
25 papers, 402 citations indexed

About

James W. Scheffel is a scholar working on Hepatology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, James W. Scheffel has authored 25 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Molecular Biology. Recurrent topics in James W. Scheffel's work include Hepatitis C virus research (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Hepatitis B Virus Studies (4 papers). James W. Scheffel is often cited by papers focused on Hepatitis C virus research (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Hepatitis B Virus Studies (4 papers). James W. Scheffel collaborates with scholars based in United States and United Kingdom. James W. Scheffel's co-authors include B. P. L. Moore, Susan J. Swartz, Isa K. Mushahwar, Sukumar P. Desai, C. Van Sant, Yoon Berm Kim, Robert J. Carrick, Richard J. Johnson, Richard R. Lesniewski and Lincoln Draper and has published in prestigious journals such as The Journal of Immunology, Hepatology and The Journal of Infectious Diseases.

In The Last Decade

James W. Scheffel

25 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James W. Scheffel United States 11 255 193 99 75 72 25 402
Jujin Satoi United States 7 286 1.1× 213 1.1× 84 0.8× 37 0.5× 24 0.3× 7 382
A. Uy Germany 11 499 2.0× 474 2.5× 75 0.8× 44 0.6× 99 1.4× 15 592
HJ Alter United States 6 286 1.1× 260 1.3× 73 0.7× 111 1.5× 49 0.7× 10 490
Emiko Takai Japan 11 311 1.2× 461 2.4× 92 0.9× 161 2.1× 29 0.4× 17 587
J. Wai-Kuo Shih United States 8 386 1.5× 400 2.1× 34 0.3× 42 0.6× 91 1.3× 9 528
N Nazarova Germany 3 238 0.9× 191 1.0× 38 0.4× 218 2.9× 36 0.5× 3 418
Maria Grazia Ruvoletto Italy 6 437 1.7× 461 2.4× 31 0.3× 41 0.5× 22 0.3× 9 552
Stefanie Grethe Germany 7 485 1.9× 421 2.2× 62 0.6× 24 0.3× 108 1.5× 10 544
G Santini Italy 10 211 0.8× 186 1.0× 15 0.2× 51 0.7× 57 0.8× 30 444
Aster Beyene United States 9 319 1.3× 279 1.4× 116 1.2× 25 0.3× 41 0.6× 10 439

Countries citing papers authored by James W. Scheffel

Since Specialization
Citations

This map shows the geographic impact of James W. Scheffel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James W. Scheffel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James W. Scheffel more than expected).

Fields of papers citing papers by James W. Scheffel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James W. Scheffel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James W. Scheffel. The network helps show where James W. Scheffel may publish in the future.

Co-authorship network of co-authors of James W. Scheffel

This figure shows the co-authorship network connecting the top 25 collaborators of James W. Scheffel. A scholar is included among the top collaborators of James W. Scheffel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James W. Scheffel. James W. Scheffel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jeffers, L., Claude F. Garon, Elizabeth R. Fischer, et al.. (1999). Persistence of hepatitis C virus in a human megakaryoblastic leukaemia cell line. Journal of Viral Hepatitis. 6(2). 107–114. 28 indexed citations
2.
Prince, Alfred M., et al.. (1999). Significance of the Anti‐E2 Response in Self‐Limited and Chronic Hepatitis C Virus Infections in Chimpanzees and in Humans. The Journal of Infectious Diseases. 180(4). 987–991. 36 indexed citations
3.
4.
Rochling, Fedja A., W.F. Jones, Kurt H. Chau, et al.. (1997). Acute Sporadic Non–A, Non–B, Non–C, Non–D, Non–E Hepatitis. Hepatology. 25(2). 478–483. 27 indexed citations
5.
Prince, A. M., James W. Scheffel, & B. P. L. Moore. (1997). A search for hepatitis C virus polymerase chain reaction‐positive but seronegative subjects among blood donors with elevated alanine aminotransferase. Transfusion. 37(2). 211–214. 6 indexed citations
6.
Kowdley, Kris V., et al.. (1997). Hepatitis C Virus Antibodies in Systemic Lupus Erythematosus. Journal of Clinical Gastroenterology. 25(2). 437–439. 24 indexed citations
7.
Jeffers, Lennox J., Ling Shao, K. Rajender Reddy, et al.. (1995). Identification of hepatitis C virus by immunoelectron microscopy. Journal of Viral Hepatitis. 2(5). 227–234. 24 indexed citations
8.
Lesniewski, Richard R., Richard J. Johnson, James W. Scheffel, et al.. (1995). Antibody to hepatitis C virus second envelope (HCV‐E2) glycoprotein: A new marker of HCV infection closely associated with viremia. Journal of Medical Virology. 45(4). 415–422. 90 indexed citations
9.
Demetris, Anthony J., et al.. (1993). Frequency and severity of HCV infection following orthotopic liver transplantation. Journal of Hepatology. 18(3). 279–283. 18 indexed citations
10.
Hayashi, Paul H., et al.. (1993). Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C. Hepatology. 18(5). 1055–1060. 45 indexed citations
11.
Scheffel, James W., et al.. (1990). RETROCELL HIV-1 Passive Hemagglutination Assay for HIV-1 Antibody Screening. JAIDS Journal of Acquired Immune Deficiency Syndromes. 3(5). 540???545–540???545. 2 indexed citations
12.
Picking, Wendy L., et al.. (1990). Anti-RNA polymerase I antibodies in the urine of patients with systemic lupus erythematosus.. PubMed. 17(10). 1308–13. 9 indexed citations
13.
Scheffel, James W., et al.. (1987). Natural cell-mediated cytotoxicity among a group of HIV seropositive hemophiliacs. Clinical Immunology Newsletter. 8(6). 86–89. 1 indexed citations
14.
Scheffel, James W. & Susan J. Swartz. (1982). Inhibition of autologous rosette formation by monoclonal antibody to the sheep erythrocyte receptor.. The Journal of Immunology. 128(4). 1930–1932. 18 indexed citations
15.
Scheffel, James W. & Susan J. Swartz. (1982). AMLR-reactive T cells isolated by autologous rosette formation. Clinical Immunology and Immunopathology. 24(1). 93–101. 4 indexed citations
16.
Scheffel, James W., et al.. (1981). Induction of polyclonal immunoglobulin synthesis in porcine peripheral blood lymphocytes by pokeweed mitogen. Developmental & Comparative Immunology. 5(2). 313–320. 4 indexed citations
17.
Scheffel, James W., et al.. (1981). Immune response to immobilized sheep erythrocyte monolayer. Journal of Immunological Methods. 46(3). 299–305. 1 indexed citations
18.
Scheffel, James W., et al.. (1979). Role of environment in the development of "natural" hemagglutinins in Minnesota miniature swine. Infection and Immunity. 26(1). 202–210. 13 indexed citations
19.
Kreutzer, Donald L., James W. Scheffel, Lincoln Draper, & D C Robertson. (1977). Mitogenic activity of cell wall components from smooth and rough strains of Brucella abortus. Infection and Immunity. 15(3). 842–845. 10 indexed citations
20.
Scheffel, James W. & Lincoln Draper. (1976). Spontaneous plaque-forming cells against autologous erythrocytes develop in cultures of normal rabbit appendix cells. Cellular Immunology. 26(1). 54–67. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jujin Satoi Breakdown of academic impact, for papers by A. Uy Breakdown of academic impact, for papers by HJ Alter Breakdown of academic impact, for papers by Emiko Takai Breakdown of academic impact, for papers by J. Wai-Kuo Shih Breakdown of academic impact, for papers by N Nazarova Breakdown of academic impact, for papers by Maria Grazia Ruvoletto Breakdown of academic impact, for papers by Stefanie Grethe Breakdown of academic impact, for papers by G Santini Breakdown of academic impact, for papers by Aster Beyene
Rankless by CCL
2026